•Concessional pricing offered in May 2000:
–Agreement with 5 pharmaceuticals and UNAIDS, “Accelerating
Access”
–To date is treating fewer than 40,000 people
world wide.
–Cost still over 1000 USD per patient per year
•Individual agreements negotiated on a product-by-product and
country-by-country basis
•Comparative price information difficult to obtain
•